GlaxoSmithKline revenue increased from £30.2 billion in 2017 to £30.8 billion in 2018, a 2.1% increase.

Annual Revenue (£)

GlaxoSmithKline revenue was £30.82 b in FY, 2018 which is a 2.1% year over year increase from the previous period.

Quarterly Revenue (£)

FY, 2016FY, 2017FY, 2018
Revenue£27.89 b£30.19 b£30.82 b
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019
Revenue£7.38 b£7.32 b£7.84 b£7.22 b£7.31 b£8.09 b£7.66 b£7.81 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

GlaxoSmithKline revenue breakdown by business segment: 25.8% from Consumer Healthcare, 16.5% from Vaccines and 57.7% from Global Pharmaceuticals

GlaxoSmithKline revenue breakdown by geographic segment: 26.9% from Europe, 36.6% from International and 36.6% from US

FY, 2018FY, 2017FY, 2016
Consumer Healthcare7.66 b7.75 b7.19 b
Vaccines5.89 b5.16 b4.59 b
Global Pharmaceuticals17.27 b17.28 b16.10 b
FY, 2018FY, 2017FY, 2016
Europe7.97 b7.94 b7.50 b
International10.87 b10.98 b10.19 b
US11.98 b11.26 b10.20 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.